Covered recipient · General Payments record
MOHAMMED NIAZI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$3,050.95
- Reported across 194 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $659.57 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $446.75 | 22 |
| Corium, Inc. | $143.22 | 9 |
| Vanda Pharmaceuticals Inc. | $28.69 | 2 |
| GlaxoSmithKline, LLC. | $24.12 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.82 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123717 | CMS |
| ABBVIE INC. | $21.98 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123719 | CMS |
| ABBVIE INC. | $25.47 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123721 | CMS |
| ABBVIE INC. | $15.06 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123723 | CMS |
| ABBVIE INC. | $116.24 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123725 | CMS |
| ABBVIE INC. | $13.98 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123727 | CMS |
| ABBVIE INC. | $12.40 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123729 | CMS |
| ABBVIE INC. | $15.27 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123731 | CMS |
| ABBVIE INC. | $13.00 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123733 | CMS |
| ABBVIE INC. | $13.45 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123735 | CMS |
| ABBVIE INC. | $14.67 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123737 | CMS |
| ABBVIE INC. | $17.49 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123739 | CMS |
| ABBVIE INC. | $15.51 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123741 | CMS |
| ABBVIE INC. | $15.29 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123743 | CMS |
| ABBVIE INC. | $13.89 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123745 | CMS |
| ABBVIE INC. | $16.81 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123747 | CMS |
| ABBVIE INC. | $12.78 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123749 | CMS |
| ABBVIE INC. | $17.17 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123751 | CMS |
| ABBVIE INC. | $15.17 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123753 | CMS |
| ABBVIE INC. | $10.90 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123755 | CMS |
| ABBVIE INC. | $17.44 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123757 | CMS |
| ABBVIE INC. | $15.96 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105123759 | CMS |
| Corium, LLC | $16.85 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100107588 | CMS |
| Corium, LLC | $16.86 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100107554 | CMS |
| Corium, LLC | $15.72 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100110992 | CMS |
| Corium, LLC | $14.15 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100114884 | CMS |
| Corium, LLC | $16.10 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100109926 | CMS |
| Corium, LLC | $13.42 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100161075 | CMS |
| Corium, LLC | $18.09 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100172304 | CMS |
| Corium, LLC | $13.06 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100160445 | CMS |
| Corium, LLC | $18.97 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100174808 | CMS |
| GlaxoSmithKline, LLC. | $24.12 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116445142 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.79 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118951404 | CMS |
| Vanda Pharmaceuticals Inc. | $14.38 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133914359 | CMS |
| Vanda Pharmaceuticals Inc. | $14.31 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133914361 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.